JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB269654

Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

HSP90AB1 KO cell lysate available now. KO validated by Next Generation Sequencing, Western blot. Free of charge wild type control included. Knockout achieved by CRISPR/Cas9; X = 8 bp deletion, 22 bp deletion; Frameshift: 100%.

View Alternative Names

90 kda heat shock protein beta HSP90 beta, D6S182, FLJ26984, HS90B_HUMAN, HSP 84, HSP 90, HSP 90 b, HSP90 BETA, HSP90AB1, HSPC2, HSPCB, Heat shock 84 kDa, Heat shock 90kD protein 1, beta, Heat shock 90kDa protein 1 beta, Heat shock protein 90 alpha family class B member 1, Heat shock protein 90 kDa, Heat shock protein 90kDa alpha (cytosolic) class B member 1, Heat shock protein 90kDa alpha family class B member 1, Heat shock protein HSP 90-beta, Heat shock protein beta

3 Images
Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)
  • WB

Lab

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)

Lane 1 : Wild-type A431 cell lysate 20 ug

Lane 2 : HSP90AB1 knockout A431 cell lysate 20 ug

Lane 3 : Saos-2 (Human osteosarcoma cell line) whole cell lysate 20 ug

Lane 4 : HL-60 (Human promyelocytic leukemia cell line) whole cell lysate 20 ug

Lanes 1 - 4 : Merged signal (red and green). Green - ab82522 observed at 85 kDa. Red - loading control, ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37kDa.

ab82522 was shown to react with Hsp90 beta in wild-type A-431 cells in western blot Loss of signal was observed when HSP90AB1 knockout cell line ab269491 (knockout cell lysate ab269654) was used. Wild-type A-431 and HSP90AB1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab82522 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Hsp90 beta antibody [K3705] (<a href='/en-us/products/primary-antibodies/hsp90-beta-antibody-k3705-ab82522'>ab82522</a>) at 1/1000 dilution

Lane 1:

Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

HSP90AB1 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-hsp90ab1-hsp90-beta-knockout-a-431-cell-line-ab269491'>ab269491</a>)

Lane 3:

Saos-2 (Human osteosarcoma cell line) whole cell lysate at 20 µg

Lane 4:

HL-60 (Human promyelocytic leukemia cell line) whole cell lysate at 20 µg

Predicted band size: 83 kDa

Observed band size: 85 kDa

false

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)
  • WB

Lab

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)

Lane 1 : Wild-type A431 cell lysate 20 ug

Lane 2 : HSP90AB1 knockout A431 cell lysate 20 ug

Lane 3 : Saos-2 (Human osteosarcoma cell line) whole cell lysate 20 ug

Lane 4 : HL-60 (Human promyelocytic leukemia cell line) whole cell lysate 20 ug

Lanes 1 - 4 : Merged signal (red and green). Green - ab82584 observed at 85 kDa. Red - loading control, ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) observed at 37kDa.

ab82584 was shown to react with Hsp90 beta in wild-type A-431 cells in western blot Loss of signal was observed when HSP90AB1 knockout cell line ab269491 (knockout cell lysate ab269654) was used. Wild-type A-431 and HSP90AB1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab82584 and ab181602 (Rabbit Anti-GAPDH antibody [EPR16891]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-Hsp90 beta antibody [K3701] (<a href='/en-us/products/primary-antibodies/hsp90-beta-antibody-k3701-ab82584'>ab82584</a>) at 1/1000 dilution

Lane 1:

Wild-type A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

HSP90AB1 knockout A-431 (Human epidermoid carcinoma cell line) whole cell lysate at 20 µg

Lane 2:

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell line (<a href='/en-us/products/cell-lines/human-hsp90ab1-hsp90-beta-knockout-a-431-cell-line-ab269491'>ab269491</a>)

Lane 3:

Saos-2 (Human osteosarcoma cell line) whole cell lysate at 20 µg

Lane 4:

HL-60 (Human promyelocytic leukemia cell line) whole cell lysate at 20 µg

Predicted band size: 83 kDa

Observed band size: 85 kDa

false

Next Generation Sequencing - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)
  • NGS

Supplier Data

Next Generation Sequencing - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell lysate (AB269654)

Knockout achieved by CRISPR/Cas9; X = 8 bp deletion, 22 bp deletion; Frameshift : 100%

Key facts

Cell type

A-431

Species or organism

Human

Tissue

Skin

Knockout validation

Next Generation Sequencing,Western blot

Mutation description

Knockout achieved by CRISPR/Cas9; X = 8 bp deletion, 22 bp deletion; Frameshift: 100%

Disease

Epidermoid Carcinoma

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }
style
left-column

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

style
left-column

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab269654-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human HSP90AB1 knockout A431 cell lysate", "number":"AB269654-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A-431 cell lysate", "number":"AB269654-CMP01", "productcode":"" } ] } } }
style
left-column

Properties and storage information

Gene name
HSP90AB1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Next Generation Sequencing, Western blot
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
style
left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Hsp90 beta also known as Hsp90AB1 or Hsp90 protein is a heat shock protein of approximately 90 kDa. It is a molecular chaperone found in most eukaryotic cells. Hsp90 beta helps in the proper folding stabilization and degradation of many proteins. Unlike its isoform Hsp90 alpha Hsp90 beta has a more stable expression and is not typically induced by stress. This protein is primarily localized in the cytosol but can also be present in other cellular compartments depending on the cellular state.
Biological function summary

Hsp90 beta functions to maintain protein homeostasis and cellular integrity. It forms part of a multi-protein chaperone complex which includes cochaperones such as Hop Hsp70 and p23 necessary for its full functionality. Hsp90 beta supports the maturation of steroid hormone receptors kinases and other client proteins. It plays an important role in the cell cycle regulation through its interaction with various proteins ensuring proper cell division and growth.

Pathways

Hsp90 beta is deeply involved in signal transduction and cellular stress response pathways. Its interaction with the Akt pathway is significant for cell survival signals. Hsp90 beta also participates in the MAP kinase pathway affecting cell growth and differentiation. The protein associates with multiple kinases including RAF and Src which are important for downstream signaling.

The dysregulation of Hsp90 beta is associated with cancer and neurodegenerative diseases. In cancer Hsp90 beta stabilizes many oncoproteins making it a potential therapeutic target for inhibiting tumor growth. It interacts with client proteins like the proto-oncogene c-Src promoting tumorigenesis. In neurodegenerative disorders such as Alzheimer's disease improper interaction between Hsp90 beta and tau proteins can contribute to disease progression impacting neuronal function.
style
left-column

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

style
left-column

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Female

style
left-column

Product protocols

style
left-column
style
left-column
style
right-column

Complementary Products

Cell Lines & Lysates

AB269491

Human HSP90AB1 (Hsp90 beta) knockout A-431 cell line

Advanced Validation

Western blot - Human HSP90AB1 (Hsp90 beta) knockout A-431 cell line (AB269491)

  • 0
  • 0
Primary Antibodies

AB303516

Anti-Hsp 90 alpha antibody [EPR27270-11]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant|KO Validated|Trial Size|Trial Size|Trial Size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Hsp 90 alpha antibody [EPR27270-11] (AB303516)

  • 0
  • 0
Primary Antibodies

AB203085

Anti-Hsp90 beta antibody [EPR16621]

20ul selling size|RabMAb|Recombinant|KO Validated

Flow Cytometry (Intracellular) - Anti-Hsp90 beta antibody [EPR16621] (AB203085)

  • 0
  • 0
Proteins & Peptides

AB318253

Recombinant Human HSP90 alpha Protein (His-tag)

Mass Spectrometry - Recombinant Human HSP90 alpha Protein (His-tag) (AB318253)

  • 0
  • 0

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com